The coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021. The market is mainly driven by factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population.

A coronary stent is a small, expandable tube-shaped device placed in the coronary arteries that supply blood to the heart. Coronary stents are used in percutaneous coronary intervention (PCI) procedures to treat patients with coronary artery disease (CAD). They are used for a wide range of indications in CAD, including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions.

Hospitals

This segment includes both government and private hospitals that provide treatment to the patients with CAD. The market for this segment is mainly driven by the rising patient pool, growing number of PCI procedures in hospitals, improving healthcare infrastructure, and favorable reimbursement scenario in developed and developing countries. In addition, major players in the coronary stents market are adopting various strategies to enhance the utilization of stents in hospitals.